List of Excipients in API CEFPODOXIME PROXETIL
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing CEFPODOXIME PROXETIL
Detailed excipient profiles for CEFPODOXIME PROXETIL
Excipient focus: ANHYDROUS CITRIC ACID
CEFPODOXIME PROXETIL drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | cefpodoxime proxetil | 16714-402 |
| Rising Pharma Holdings Inc | cefpodoxime proxetil | 64980-402 |
| Aurobindo Pharma Limited | cefpodoxime proxetil | 65862-140 |
| >Company | >Ingredient | >NDC |
CEFPODOXIME PROXETIL drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: CARBOXYMETHYLCELLULOSE CALCIUM
CEFPODOXIME PROXETIL drug variants containing CARBOXYMETHYLCELLULOSE CALCIUM
CEFPODOXIME PROXETIL drug variants not containing CARBOXYMETHYLCELLULOSE CALCIUM
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | cefpodoxime proxetil | 16714-402 |
| Rising Pharma Holdings Inc | cefpodoxime proxetil | 64980-402 |
| Aurobindo Pharma Limited | cefpodoxime proxetil | 65862-140 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
CEFPODOXIME PROXETIL drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | cefpodoxime proxetil | 16714-402 |
| Rising Pharma Holdings Inc | cefpodoxime proxetil | 64980-402 |
| Aurobindo Pharma Limited | cefpodoxime proxetil | 65862-140 |
| >Company | >Ingredient | >NDC |
CEFPODOXIME PROXETIL drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Excipient focus: CELLULOSE, MICROCRYSTALLINE
CEFPODOXIME PROXETIL drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | cefpodoxime proxetil | 16714-402 |
| Rising Pharma Holdings Inc | cefpodoxime proxetil | 64980-402 |
| Aurobindo Pharma Limited | cefpodoxime proxetil | 65862-140 |
| >Company | >Ingredient | >NDC |
CEFPODOXIME PROXETIL drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
CEFPODOXIME PROXETIL drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | cefpodoxime proxetil | 16714-402 |
| Rising Pharma Holdings Inc | cefpodoxime proxetil | 64980-402 |
| Aurobindo Pharma Limited | cefpodoxime proxetil | 65862-140 |
| >Company | >Ingredient | >NDC |
CEFPODOXIME PROXETIL drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
CEFPODOXIME PROXETIL drug variants containing CROSPOVIDONE
CEFPODOXIME PROXETIL drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | cefpodoxime proxetil | 16714-402 |
| Rising Pharma Holdings Inc | cefpodoxime proxetil | 64980-402 |
| Aurobindo Pharma Limited | cefpodoxime proxetil | 65862-140 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
CEFPODOXIME PROXETIL drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| PD-Rx Pharmaceuticals Inc | cefpodoxime proxetil | 55289-393 |
| >Company | >Ingredient | >NDC |
CEFPODOXIME PROXETIL drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 5
CEFPODOXIME PROXETIL drug variants containing FD&C YELLOW NO. 5
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | cefpodoxime proxetil | 67877-559 |
| Amici Pharmaceuticals LLC | cefpodoxime proxetil | 69292-510 |
| Amici Pharmaceuticals LLC | cefpodoxime proxetil | 69292-514 |
| >Company | >Ingredient | >NDC |
CEFPODOXIME PROXETIL drug variants not containing FD&C YELLOW NO. 5
Excipient focus: FD&C YELLOW NO. 6
CEFPODOXIME PROXETIL drug variants containing FD&C YELLOW NO. 6
CEFPODOXIME PROXETIL drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | cefpodoxime proxetil | 16714-402 |
| Rising Pharma Holdings Inc | cefpodoxime proxetil | 64980-402 |
| Aurobindo Pharma Limited | cefpodoxime proxetil | 65862-140 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
CEFPODOXIME PROXETIL drug variants containing FERRIC OXIDE RED
CEFPODOXIME PROXETIL drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
CEFPODOXIME PROXETIL drug variants containing FERRIC OXIDE YELLOW
CEFPODOXIME PROXETIL drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: HYDROXYPROPYL CELLULOSE
CEFPODOXIME PROXETIL drug variants containing HYDROXYPROPYL CELLULOSE
CEFPODOXIME PROXETIL drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
CEFPODOXIME PROXETIL drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | cefpodoxime proxetil | 0781-5438 |
| >Company | >Ingredient | >NDC |
CEFPODOXIME PROXETIL drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
CEFPODOXIME PROXETIL drug variants containing HYPROMELLOSE 2910
CEFPODOXIME PROXETIL drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
CEFPODOXIME PROXETIL drug variants containing HYPROMELLOSES
CEFPODOXIME PROXETIL drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
CEFPODOXIME PROXETIL drug variants containing LACTOSE MONOHYDRATE
CEFPODOXIME PROXETIL drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
CEFPODOXIME PROXETIL drug variants containing MAGNESIUM STEARATE
CEFPODOXIME PROXETIL drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | cefpodoxime proxetil | 16714-402 |
| Rising Pharma Holdings Inc | cefpodoxime proxetil | 64980-402 |
| Aurobindo Pharma Limited | cefpodoxime proxetil | 65862-140 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
CEFPODOXIME PROXETIL drug variants containing POLYETHYLENE GLYCOL
CEFPODOXIME PROXETIL drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: PROPYLENE GLYCOL
CEFPODOXIME PROXETIL drug variants containing PROPYLENE GLYCOL
CEFPODOXIME PROXETIL drug variants not containing PROPYLENE GLYCOL
Excipient focus: SILICON DIOXIDE
CEFPODOXIME PROXETIL drug variants containing SILICON DIOXIDE
CEFPODOXIME PROXETIL drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BENZOATE
CEFPODOXIME PROXETIL drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | cefpodoxime proxetil | 16714-402 |
| Rising Pharma Holdings Inc | cefpodoxime proxetil | 64980-402 |
| Aurobindo Pharma Limited | cefpodoxime proxetil | 65862-140 |
| >Company | >Ingredient | >NDC |
CEFPODOXIME PROXETIL drug variants not containing SODIUM BENZOATE
Excipient focus: SODIUM LAURYL SULFATE
CEFPODOXIME PROXETIL drug variants containing SODIUM LAURYL SULFATE
CEFPODOXIME PROXETIL drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | cefpodoxime proxetil | 16714-402 |
| Rising Pharma Holdings Inc | cefpodoxime proxetil | 64980-402 |
| Aurobindo Pharma Limited | cefpodoxime proxetil | 65862-140 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
CEFPODOXIME PROXETIL drug variants containing STARCH, CORN
CEFPODOXIME PROXETIL drug variants not containing STARCH, CORN
Excipient focus: SUCROSE
CEFPODOXIME PROXETIL drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | cefpodoxime proxetil | 16714-402 |
| Rising Pharma Holdings Inc | cefpodoxime proxetil | 64980-402 |
| Aurobindo Pharma Limited | cefpodoxime proxetil | 65862-140 |
| >Company | >Ingredient | >NDC |
CEFPODOXIME PROXETIL drug variants not containing SUCROSE
Excipient focus: TALC
CEFPODOXIME PROXETIL drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | cefpodoxime proxetil | 0781-5438 |
| >Company | >Ingredient | >NDC |
CEFPODOXIME PROXETIL drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
CEFPODOXIME PROXETIL drug variants containing TITANIUM DIOXIDE
CEFPODOXIME PROXETIL drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | cefpodoxime proxetil | 16714-402 |
| Rising Pharma Holdings Inc | cefpodoxime proxetil | 64980-402 |
| Aurobindo Pharma Limited | cefpodoxime proxetil | 65862-140 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
CEFPODOXIME PROXETIL drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | cefpodoxime proxetil | 16714-402 |
| Rising Pharma Holdings Inc | cefpodoxime proxetil | 64980-402 |
| Aurobindo Pharma Limited | cefpodoxime proxetil | 65862-140 |
| >Company | >Ingredient | >NDC |
CEFPODOXIME PROXETIL drug variants not containing TRISODIUM CITRATE DIHYDRATE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
